Skip to main content

Table 2 Prevalence of MES in various patient subgroups along with OR for the subgroups that are significantly associated with MES (n = 40).

From: Microemboli-monitoring during the acute phase of ischemic stroke: Is it worth the time?

Group

 

%

OR

p-value

Age

< 65

5.9

9

0.03

 

≥ 65

36.4

  

Sex

Male

20.7

 

0.26

 

Female

36.4

  

Stroke type

Stroke

24.3

 

0.58

 

TIA

0

  

NIHSS

0-7

15

Ref

0.02

 

8-13

8.3

14

 
 

> 13

71.4

28

 

Intravenous thrombolysis

Yes

29.2

 

0.36

 

No

18.8

  

Etiology-TOAST

Embolic

33.3

7

0.06

 

Non-embolic

12.5

  

Intracranial stenosis

No

16.7

10

0.04

 

Yes

66.7

  

Previous stroke/TIA

No

14.8

4.8

0.06

 

Yes

45.5

  

Atrial fibrillation

No

23.1

 

0.13

 

yes

60

  

Active Smokers

No

28

 

0.6

 

yes

25

  
  1. * OR calculated using Chi-square for dichotomous variables and logistic regression for polytomous variables.
  2. NIHSS = National Institute of Health Stroke Scale
  3. TOAST = Trial of Org 10172 in Acute Stroke Treatment
  4. TIA = Transient ischemic attack